Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2026-02-26 @ 7:25 PM
Study NCT ID:
NCT02812693
Status:
WITHDRAWN
Last Update Posted:
2018-04-05
First Post:
2016-06-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification
Sponsor:
Joanne Jeter
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-04
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-20
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-22
First Submit QC Date:
None
Study First Post Date:
2016-06-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-03
Last Update Post Date:
2018-04-05
Last Update Post Date Type:
ACTUAL